All News

Extremity Reconstruction Market – Detailed Study Analysis and Forecast by 2025

24 MARCH 2017 By MILITARY NEWS Albany, NY — (SBWIRE) — 03/24/2017 — Global Extremity Reconstruction Market: Overview The increasing incidence of injuries, abnormalities, and congenital defects in the upper or lower extremity of human body has fuelled the demand for reconstructive surgical procedures. Implant devices for the shoulder, wrist, ankle […]

InVivo to Initiate Cervical Spinal Cord Injury Study

March 23, 2017 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that Health Canada has approved the company’s Investigational Testing Authorization application to commence a clinical study of the Neuro-Spinal Scaffold™ in patients with acute, complete (AIS A) cervical (C5-T1) spinal cord injuries (SCIs). InVivo currently is in late stage […]

Alphatec Holdings Announces $18.9 Million Private Placement

CARLSBAD, Calif., March 23, 2017 (GLOBE NEWSWIRE) — Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, announced today that it has entered into a definitive securities purchase agreement to raise approximately $18.9 million in a private placement of common stock, Series […]

Stamford Health Names New Chair Of Orthopedic Surgery Department

By John Haffey – March 21, 2017 STAMFORD, Conn. — Dr. Charles “Chip” Cornell has been named chair of the newly created Department of Orthopedic Surgery at Stamford Health, effective March 1. As department chair, Cornell will be responsible for the direction of all orthopedic services, including subspecialty divisions and HSS Orthopedics […]

SpineGuard Reports Full-Year 2016 Financial Results

March 23, 2017 PARIS & SAN FRANCISCO–(BUSINESS WIRE)–Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that develops and markets disposable medical devices designed to make spine surgery safer, reported today its full-year 2016 financial results as approved by the Board of Directors on March 23, 2017. € thousands – […]

Centrexion Therapeutics to Present Data on CNTX-4975 from the Treatment of Knee Osteoarthritis Pain at IX SIMPAR-ISURA

March 23, 2017 BOSTON–(BUSINESS WIRE)–Centrexion Therapeutics, a company focused on advancing the treatment of chronic pain with one of the largest exclusively pain-focused pipelines of non-opioid therapies in active development, today announced it will present 12-week data from TRIUMPH, a Phase 2b clinical trial of CNTX-4975 for the treatment of moderate to severe […]

Proposed US FDA User Fee Increase would Impact Smaller Medical Device Firms the Most

March 20, 2017 by Stewart Eisenhart EMERGO SUMMARY OF KEY POINTS: The Trump Administration has proposed user fee increases for drug, medical device and other FDA registrants in 2018. Few specifics on the proposed increases make it difficult to determine exactly how medical device firms would be impacted. Smaller manufacturers […]

Medtronic Announces Pricing of $2 Billion of Senior Notes

DUBLIN – March 21, 2017 – Medtronic plc (MDT) announced today that its wholly-owned subsidiary, Medtronic Global Holdings S.C.A. (“Medtronic Luxco”), has priced an offering of $1,000,000,000 principal amount of 1.700 percent senior notes due 2019 and $850,000,000 principal amount of 3.350 percent senior notes due 2027 (collectively, the “notes”). […]

Global Spine Biologics Market Expected to Reach $2,214 Million by 2022 – Allied Market Research

PORTLAND, Oregon and PUNE, India, March 22, 2017 /PRNewswire/ — Global spine biologics market was valued at $1,644 million in 2015, and is projected to reach $2,214 million by 2022, growing at a CAGR of 4.3% during the forecast period 2014-2022, according to a new report published by Allied Market […]

2016: A Historic Year for VEXIM

March 22, 2017 02:00 AM Eastern Daylight Time TOULOUSE, France–(BUSINESS WIRE)–Regulatory News: VEXIM (Paris:ALVXM) (FR0011072602 – ALVXM), a medical device company specializing in the minimally invasive treatment of vertebral fractures, today announces its consolidated annual results (IFRS1) as of December 31st, 20162. « Our 2016 results represent a historic turning point […]

© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1